Stamford, CT -- (SBWIRE) -- 12/14/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Novavax, Inc. (NASDAQ:NVAX), Myriad Genetics, Inc. (NASDAQ:MYGN), McDermott International (NYSE:MDR),Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
Novavax, Inc. (NASDAQ:NVAX) managed to keep its fall at -2.03% on below -normal volume of 3.04M shares. The stock settled at $3.87 after floating in a range of $3.80 to $4.04. Its latest price has reached market capitalization of $1.07 billion. Its 52-week range has been $1.68 to $4.34. GT Advanced Technologies Inc. is diversified technology company with crystal growth equipment and solutions for the global solar, light emitting diode (LED) and electronics industries. The Company operates in three segments: its polysilicon business, its photovoltaic (PV), business and its sapphire business.
Has NVAX Found The Bottom and Ready To Move Up? Find Out Here
Myriad Genetics, Inc. (NASDAQ:MYGN) traded down on a volume of 3.19 million, higher than its standard daily volume. Shares have dropped-1.32% to $23.93. Over the last twelve months, the stock has lost/-11.21% and faced a worst price of $22.20. Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis.
Has MYGN Found The Bottom And Ready To Gain Momentum? Find Out Here
McDermott International (NYSE:MDR) settled -0.25% lower at $8.03 on below -normal volume of 2.89M shares during the last trading day. The stock has its 12-month high at $13.48 and 52-week low price was $6.68. It traded in a range of $7.93 to $8.11 during the last trading day. McDermott International, Inc. (MII) is a engineering, procurement, construction and installation (EPCI) company. The Company is focused on designing and executing complex offshore oil and gas projects worldwide. The Company provides fully integrated EPCI services; it delivers fixed and floating production facilities, pipeline installations and subsea systems from concept to commissioning. Its business segments consist of Asia Pacific, Atlantic, Caspian and the Middle East. On March 19, 2012, the Company completed the sale of its former charter fleet business, which operated 10 of the 14 vessels.
Will MDR Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Merrimack Pharmaceuticals Inc (NASDAQ:MACK) showed no change on high volume, trading at a volume of 2.96M shares versus its average daily volume of 2.65 million shares. At $4.54, the stock has attained market capitalization of $464.66 million. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.
Can TVIX Show a Strong Recovery? Find out in This Research Report
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)